Ligand validation:1ML3

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1ML3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1ML3_NAD_D_1361	79%	19%	0.121	0.967	1.64	1.81	6	8	2	0	100%	1
1ML3_NAD_C_1360	13%	19%	0.283	0.82	1.58	1.84	6	10	0	0	100%	0.5
1ML3_NAD_B_1362	2%	19%	0.386	0.69	1.67	1.79	8	9	3	0	100%	0.511
3DMT_NAD_C_360	87%	36%	0.098	0.97	1.09	1.4	3	6	8	0	100%	1
3IDS_NAD_D_360	72%	35%	0.112	0.937	1.31	1.24	2	3	1	0	100%	0.977
1QXS_NAD_D_861	68%	17%	0.142	0.953	1.75	1.86	7	10	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.